Literature DB >> 19234763

Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7.

Sahil Adriouch1, Felix Scheuplein, Robert Bähring, Michel Seman, Olivier Boyer, Friedrich Koch-Nolte, Friedrich Haag.   

Abstract

The cytolytic P2X7 purinoceptor is widely expressed on leukocytes and has sparked interest because of its key role in the activation of the inflammasome, the release of the pro-inflammatory cytokine IL-1beta and cell death. We report here the functional characterisation of a R276A gain-of-function mutant analysed for its capacities to induce membrane depolarisation, calcium influx and opening of a large membrane pore permeable to YO-PRO-1. Our results highlight the particular sensitivity of R276A mutant to low micromolar adenosine triphosphate (ATP) concentrations, which possibly reflect an increased affinity for its ligands, and a slower closing kinetics of the receptor channel. Our findings support the notion that evolutionary pressures maintain the low sensitivity of P2X7 to ATP. We also believe that the R276A mutant described here may be useful for the generation of new animal models with exacerbated P2X7 functions that will serve to better characterise its role in inflammation and in immune responses.

Entities:  

Year:  2009        PMID: 19234763      PMCID: PMC2686824          DOI: 10.1007/s11302-009-9134-6

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  60 in total

Review 1.  Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

Authors:  Eduardo R Lazarowski; Richard C Boucher; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

Review 2.  Pathophysiology and therapeutic potential of purinergic signaling.

Authors:  Geoffrey Burnstock
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

3.  ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site.

Authors:  Sahil Adriouch; Peter Bannas; Nicole Schwarz; Ralf Fliegert; Andreas H Guse; Michel Seman; Friedrich Haag; Friedrich Koch-Nolte
Journal:  FASEB J       Date:  2007-10-10       Impact factor: 5.191

Review 4.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

Authors:  F Di Virgilio; P Chiozzi; D Ferrari; S Falzoni; J M Sanz; A Morelli; M Torboli; G Bolognesi; O R Baricordi
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

5.  A new monoclonal antibody detects a developmentally regulated mouse ecto-ADP-ribosyltransferase on T cells: subset distribution, inbred strain variation, and modulation upon T cell activation.

Authors:  F Koch-Nolte; T Duffy; M Nissen; S Kahl; N Killeen; V Ablamunits; F Haag; E H Leiter
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

Review 6.  P2X receptors as cell-surface ATP sensors in health and disease.

Authors:  Baljit S Khakh; R Alan North
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

7.  A 5' intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1-2% of the Caucasian population.

Authors:  Kristen K Skarratt; Stephen J Fuller; Ronald Sluyter; Lan-Phuong Dao-Ung; Ben J Gu; James S Wiley
Journal:  FEBS Lett       Date:  2005-04-14       Impact factor: 4.124

8.  Identification of amino acid residues contributing to the ATP-binding site of a purinergic P2X receptor.

Authors:  L H Jiang; F Rassendren; A Surprenant; R A North
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

9.  Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line.

Authors:  B D Humphreys; G R Dubyak
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

10.  An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor.

Authors:  Ben J Gu; Ronald Sluyter; Kristen K Skarratt; Anne N Shemon; Lan-Phuong Dao-Ung; Stephen J Fuller; Julian A Barden; Alison L Clarke; Steven Petrou; James S Wiley
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

View more
  6 in total

1.  A putative extracellular salt bridge at the subunit interface contributes to the ion channel function of the ATP-gated P2X2 receptor.

Authors:  Ruotian Jiang; Adeline Martz; Sophie Gonin; Antoine Taly; Lia Prado de Carvalho; Thomas Grutter
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

2.  Residues 155 and 348 contribute to the determination of P2X7 receptor function via distinct mechanisms revealed by single-nucleotide polymorphisms.

Authors:  Helen J Bradley; Jocelyn M Baldwin; G Ranjan Goli; Brian Johnson; Jie Zou; Asipu Sivaprasadarao; Stephen A Baldwin; Lin-Hua Jiang
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

3.  Comparative study of the P2X gene family in animals and plants.

Authors:  Zhuoran Hou; Jun Cao
Journal:  Purinergic Signal       Date:  2016-02-13       Impact factor: 3.765

Review 4.  Structural and molecular modeling features of P2X receptors.

Authors:  Luiz Anastacio Alves; João Herminio Martins da Silva; Dinarte Neto Moreira Ferreira; Antonio Augusto Fidalgo-Neto; Pedro Celso Nogueira Teixeira; Cristina Alves Magalhães de Souza; Ernesto Raúl Caffarena; Mônica Santos de Freitas
Journal:  Int J Mol Sci       Date:  2014-03-14       Impact factor: 5.923

5.  Insights into the Molecular Mechanisms Underlying Mammalian P2X7 Receptor Functions and Contributions in Diseases, Revealed by Structural Modeling and Single Nucleotide Polymorphisms.

Authors:  Lin-Hua Jiang; Jocelyn M Baldwin; Sebastien Roger; Stephen A Baldwin
Journal:  Front Pharmacol       Date:  2013-05-07       Impact factor: 5.810

Review 6.  Structural basis for the functional properties of the P2X7 receptor for extracellular ATP.

Authors:  Lin-Hua Jiang; Emily A Caseley; Steve P Muench; Sébastien Roger
Journal:  Purinergic Signal       Date:  2021-05-13       Impact factor: 3.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.